Drug list update set for October 1 |
|
We review our drug lists several times a year. Here's what's changing on October 1:
Medication: Atripla
- National /Preferred: Moves from Tier 2 to Tier 3
- National Closed: Moves from Tier 2 to Non-formulary (not covered)
Members currently on Atripla are authorized to use it for life. So this change impacts only new prescriptions.
Medication: Chlorzoxazone 250 mg
- National/Preferred and National Closed: Moves from Tier 1 to Non-formulary (not covered)
- Essential Drug List: Moves from Tier 1 to Non-formulary (not covered)
- Generic Premium: Moves from Tier 1 to Non-formulary (not covered)
Members now using Chlorzoxazone 250 mg may continue on their current therapy until November 1, 2019.
We'll notify members who've had claims for these drugs in the last 12 months of the change. Letters start mailing August 30, 2019.
Questions? Members should call the Member Services number on their ID cards.
|
|
|
|
|
|
|
|
|
|
|